Latest market price
12.45
-0.34-2.66%
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | -0.03 | Insider Own | 1.27% | Shs Outstand | 141.55M | Perf Week | -3.34% |
| Market Cap | 1.76B | Forward P/E | 4.45 | EPS next Y | 2.80 | Insider Trans | -1.94% | Shs Float | 141.25M | Perf Month | -9.85% |
| Enterprise Value | 21.04B | PEG | — | EPS next Q | 0.72 | Short Float | 12.27% | Perf Quarter | -23.76% | ||
| Income | -52.00M | P/S | 1.98 | EPS this Y | -8.58% | Short Ratio | 4.35 | Perf Half Y | -29.78% | ||
| Sales | 890.00M | P/B | 0.75 | EPS next Y | -2.54% | ROA | -0.23% | Short Interest | 17.34M | Perf YTD | -29.62% |
| Book/sh | 16.61 | P/C | 17.62 | EPS next 5Y | 0.43% | ROE | -2.19% | 52W High | 19.31 -35.53% | Perf Year | -23.20% |
| Cash/sh | 0.71 | P/FCF | 3.86 | EPS past 3/5Y | — | ROIC | 4.59% | 52W Low | 12.28 1.38% | Perf 3Y | -12.45% |
| Dividend Est. | 2.88 (23.13%) | EV/EBITDA | 39.70 | Sales past 3/5Y | — | Gross Margin | 94.60% | Volatility | 2.62% 3.16% | Perf 5Y | -76.71% |
| Dividend TTM | 2.88 (23.13%) | EV/Sales | 23.64 | EPS Y/Y TTM | — | Oper. Margin | — | ATR (14) | 0.39 | Perf 10Y | -88.86% |
| Dividend Ex-Date | Nov 16, 2026 | Quick Ratio | 0.03 | Sales Y/Y TTM | 21.25% | Profit Margin | -5.85% | RSI (14) | 31.00 | Recom | 3.00 |
| Dividend Gr. 3/5Y | -21.70% -13.65% | Current Ratio | 0.03 | EPS Q/Q | -1.39% | SMA20 | -4.88% | Beta | 1.44 | Target Price | 13.83 |
| Payout | — | Debt/Eq | 8.24 | Sales Q/Q | -30.28% | SMA50 | -13.73% | Rel Volume | 1.23 | Prev Close | 12.79 |
| Employees | 20 | LT Debt/Eq | 0.00 | Earnings | Feb 17 | SMA200 | -24.56% | Avg Volume | 4.29M | Price | 12.45 |
| IPO Date | Dec 03, 2007 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -0.39% — | Net Debt/EBITDA | 36.38 | Volume | 5,285,312 | Change | -2.66% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jun-04-26 | Reiterated | RBC Capital | $13 | |
| Jun-04-26 | Reiterated | BTIG | $14 | |
| Apr-24-26 | Reiterated | UBS | Neutral | $16 → $18 |
| Jan-16-26 | Upgrade | Jones Trading | Hold → Buy | |
| Dec-15-25 | Initiated | Compass Point | Buy | $19 |
| Oct-08-25 | Reiterated | UBS | Neutral | $16 |
| Apr-28-25 | Upgrade | Janney Montgomery Scott | Neutral → Buy | |
| Jun-02-23 | Reiterated | Needham | $19 | |
| May-03-22 | Reiterated | Credit Suisse | Neutral | $7.50 |
| May-02-22 | Reiterated | Credit Suisse | Neutral | $7.50 |
Latest News· Times ET
Oct-28-26
Oct-28-2601:49PM
Oct-27-26
Oct-27-2612:02AM
Oct-25-26
Oct-25-2611:00PM
02:45PM
REITs Rebound As Earnings Deliverseekingalpha.com
10:00AM
Oct-24-26
Oct-24-2601:14PM
Oct-22-26
Oct-22-2611:37AM
10:04AM
ARMOUR Residential REIT Q3 Earnings Call Highlightsmarketbeat.com
04:35AM
Oct-21-26
04:15PM
Oct-20-26
Oct-20-2604:30PM
04:20PM
04:15PM
Oct-14-26
Company
ARMOUR Residential REIT, Inc. (ARR), founded in 2008 and based in Vero Beach, Florida, primarily allocates its capital to residential mortgage-backed securities (MBS) within the United States. Its investment holdings predominantly comprise MBS that are either issued or guaranteed by U.S. Government-sponsored entities (GSEs) and the Government National Mortgage Association (GNMA. These securities are underpinned by various home loans, including fixed-rate, hybrid adjustable-rate, and adjustable-rate mortgages. The company's portfolio also encompasses unsecured debt instruments and bonds from GSEs, U.S. Treasury securities, and money market funds. Furthermore, ARR invests in other residential mortgage-backed securities where the principal and interest payments lack a guarantee from a GSE or other government agency. As a Real Estate Investment Trust (REIT) under the Internal Revenue Code, the company benefits from an exemption from corporate income tax on the portion of its net earnings that is distributed to its shareholders.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 890 | 1,305 | 240 | 450 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 48 | 39 | 33 | 32 | — | — | — | — | — | |
| Gross Profit | 842 | 1,266 | 207 | 418 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 16 | 0 | 38 | 37 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | -173 | 302 | -341 | -77 | — | — | — | — | — | |
| Operating Income | 999 | 965 | 510 | 458 | — | — | — | — | — | |
| Interest Expense | 742 | 642 | 524 | 526 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -308 | 0 | 0 | 0 | — | — | — | — | — | |
| Net Income Before Taxes | -52 | 323 | -14 | -68 | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Consolidated Net Income | -52 | 323 | -14 | -68 | — | — | — | — | — | |
| Net Income From Continuing Operations | -52 | 323 | -14 | -68 | — | — | — | — | — | |
| Net Income | -52 | 323 | -14 | -68 | — | — | — | — | — | |
| EPS (Recurring) | -0.03 | 3.31 | -0.51 | -1.86 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.03 | 3.31 | -0.51 | -1.86 | — | — | — | — | — | |
| EPS (Diluted) | -0.03 | 3.30 | -0.51 | -1.86 | — | — | — | — | — | |
| EBITDA | 530 | 967 | 510 | 458 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | 5.36 | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 2.03 | 1.27 | 4.09 | 1.85 | — | — | — | — | — | |
| Gross Margin | 94.61 | 97.01 | 86.25 | 92.89 | — | — | — | — | — | |
| Operating Margin | 112.25 | 73.95 | 212.50 | 101.78 | — | — | — | — | — | |
| Net Margin | -5.84 | 24.75 | -5.83 | -15.11 | — | — | — | — | — | |
| Shares Outstanding | 145 | 94 | 52 | 43 | — | — | — | — | — | |
| Market Capitalization | 1,805 | 1,663 | 981 | 831 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Losyev Sergey | Co-Chief Investment Officer | Sep 29 '26 | Buy | 13.91 | 725 | 10,085 | 9,677 | Sep 30 |
| STATON DANIEL C | Chairman of the Board | Sep 10 '26 | Sale | 15.86 | 35,583 | 564,418 | 0 | Sep 11 |
| Behar Z Jamie | Director | Aug 21 '26 | Option Exercise | 0.00 | 1,900 | 0 | 17,344 | Aug 25 |
| Downey Carolyn | Director | Aug 21 '26 | Option Exercise | 0.00 | 1,900 | 0 | 30,719 | Aug 25 |
| HOLLIHAN JOHN P III | Director | Aug 21 '26 | Option Exercise | 0.00 | 1,900 | 0 | 22,141 | Aug 25 |
| Hain Robert C | Director | Aug 21 '26 | Option Exercise | 0.00 | 1,900 | 0 | 4,381 | Aug 25 |
| PAPERIN STEWART J | Director | Aug 21 '26 | Option Exercise | 0.00 | 1,900 | 0 | 14,095 | Aug 25 |
| BELL MARC H | Director | Aug 21 '26 | Option Exercise | 0.00 | 2,380 | 0 | 31,161 | Aug 25 |
| STATON DANIEL C | Chairman of the Board | Aug 21 '26 | Option Exercise | 0.00 | 2,380 | 0 | 35,583 | Aug 25 |
| Losyev Sergey | Co-Chief Investment Officer | Aug 21 '26 | Option Exercise | 0.00 | 4,000 | 0 | 10,070 | Aug 25 |
| Macauley Desmond | Co-Chief Investment Officer | Aug 21 '26 | Option Exercise | 0.00 | 4,000 | 0 | 10,470 | Aug 25 |
| Harper Gordon | CFO | Aug 21 '26 | Option Exercise | 0.00 | 7,750 | 0 | 37,066 | Aug 25 |
| ULM SCOTT | CEO | Aug 21 '26 | Option Exercise | 0.00 | 10,880 | 0 | 87,738 | Aug 25 |
| HOLLIHAN JOHN P III | Director | May 21 '26 | Option Exercise | 0.00 | 1,900 | 0 | 21,001 | May 26 |
| Behar Z Jamie | Director | May 21 '26 | Option Exercise | 0.00 | 1,900 | 0 | 15,444 | May 26 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.